We recommend that when you or your family member is diagnosed with mesothelioma that you be evaluated at an academic, multi-disciplinary, mesothelioma center. In order to help you become familiar with what a center can offer, we feature one center per month.
The Mesothelioma Treatment Center Baylor College of Medicine
- 6620 Main Street
- Houston, Texas
Baylor St. Luke’s Medical Center
- 6720 Bertner Avenue,
- Houston, Texas
Mission- “Quality Life Extension Leading to a Cure.” David J Sugarbaker, MD Program has a three-part approach, treatment program, research program, and support program.
The program was founded in July of 2014 by Dr. David Sugarbaker, an international expert in mesothelioma. The program was founded due to the rising incidence of mesothelioma worldwide, and the advantages of specialized care. It is a multidisciplinary team approach program consisting of a treatment program, a research program, and a support program.
Director: Dr. David Sugarbaker Professor and Chief Division of General Thoracic Surgery Michael E. DeBakey Department of Surgery at Baylor College of Medicine.
Team: Dr. David Sugarbaker, Dr. Bryan Burt, Dr. Shawn Groth, Dr. Ori Wald, surgeons. Oncologist Dr. Eugene Choi and Dr. Jun Zhang Radiation oncologists, Nurses, Medical Assistants, Physician Assistants,
Fellows, Residents, Nutritionist, Clinical Research Associates, Surgical Coordinators, Mesothelioma Coordinator, Social Worker, Chaplaincy, Patient Advocate.
Affiliations: Baylor University School of Medicine Houston
Stats: Founded in July 2014. To date has seen a total of 200 patients from all over the world with mesothelioma
Research: Currently on www.clinicaltrials.gov there are 2 clinical trials listed as active at the mesothelioma center. Both are enrolling patients. The first is a multi-center trial to see the efficacy and safety of anetumab ravtansine versus vinorelbine in progression free survival in patients with stage IV mesothelin overexpressing malignant pleural mesothelioma. The second is MED14736 Or MED14736 + Tremelimumab In Surgically Resectable Malignant Pleural Mesothelioma. Dr. Bryan Burt is the Director of General Thoracic Surgery Research.
Support Services: Spiritual, Care Management and Social Work, Nutrition, List of accommodation options available with discounts for patients and families.
Contact: Chelsea Odom, Patient Navigator 713-798-9159 Chelsea.Odom@bcm.edu
Schedule/Change/Alter Appointments: 713-798-6376
